Ignite Creation Date:
2024-05-06 @ 11:17 AM
Last Modification Date:
2024-10-26 @ 12:43 PM
Study NCT ID:
NCT03481998
Status:
COMPLETED
Last Update Posted:
2023-11-21
First Post:
2018-03-14
Brief Title:
A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Organization Data
Organization:
Jiangsu HengRui Medicine Co Ltd
Class:
INDUSTRY
Study ID:
SHR6390-IbII-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jiangsu HengRui Medicine Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None